Mark L. Day, Ph.D.
Associate Professor of Urology
Having received his bachelors degree in microbiology at Indiana University, Dr. Day spent three years as a research molecular biologist with the Monsanto Company in St. Louis, MO.
He then started at Washington University to pursue his Ph.D. in molecular cell biology.
He stayed on at the university to be an instructor in urologic surgery before coming to the University of Michigan.
Dr. Day has been awarded the Junior Faculty Research Award by the American Cancer Society.
Dr. Day's research has resulted in the following publications over the past year:
"Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate,"
"Sex Hormone-induced Carcinogenesis in Rb-deficient Prostate Tissue," "Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors,"
"Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and
mammary involution." Dr. Day has authored and co-authored a number of publications in this field and has presented his research at national and international conferences.
For more information, Dr. Day can be contacted at:
Department of Urology
University of Michigan Medical Center
1500 E. Medical Center Drive
Ann Arbor, MI 48109-0330
Office Number: (734) 647-8121